Luspatercept

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Luspatercept
Treatment and conditionWhere it standsTrials
Luspatercept for anemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Luspatercept for myelodysplastic syndromesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Luspatercept for primary myelofibrosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2